Non-Comparative, Two-Cohort, Single Arm, Open-Label, Phase 2 Study of Nivolumab *BMS-936558) in classical Hodgkin Lymphoma (cHL) Subjects after Failure of Autologous Stem Cell Transplant (ASCT)

Type of Cancer
Lymphoma

Site
Hackensack

Sponsor
Bristol-Myers Squibb

Protocol Number
CA209-205

To Learn More Call
201-510-0910